DRUG

LWE

3 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for LWE

ALS 3

Mediator Outcome Score Tier Lit. status Trial
SOD1 ALS 0.383 High novel signal none
SOD1 familial amyotrophic lateral sclerosis 0.248 Mid novel signal none
SOD1 familial ALS 0.230 Mid novel signal none

Clinical trials

1 registered trial for LWE

Source: ClinicalTrials.gov